Ki-67 and Bcl-2 antigen expression in adenomatous colorectal polyps from women with breast cancer

Ann Surg Oncol. 2010 Sep;17(9):2378-83. doi: 10.1245/s10434-010-0968-5. Epub 2010 Feb 23.

Abstract

Background: The aim of this study was to evaluate Ki-67 and Bcl-2 antigen expression in colorectal polyps from women with breast cancer.

Methods: A randomized, controlled study was carried out in 35 women, either with or without breast cancer, who had adenomatous colorectal polyps. The patients were divided into two groups: group A (without breast cancer; control group; n = 17) and group B (with breast cancer; study group; n = 18). Immunohistochemistry was performed on the colorectal polyps to evaluate Ki-67 and Bcl-2 antigen expression. Student's t-test and the chi(2) test were used for the statistical analysis of Ki-67 and Bcl-2 expression, respectively. Statistical significance was established as P < 0.05.

Results: The mean percentage of Ki-67-stained nuclei in groups A and B was 36.25 +/- 2.31 and 59.44 +/- 3.34 (+/- SEM), respectively (P < 0.0001), while the percentage of cases with cells expressing Bcl-2 in groups A and B was 23.5 and 77.8%, respectively (P < 0.001).

Conclusions: In the present study, there was greater proliferative activity and greater expression of the antiapoptotic protein Bcl-2 in the colorectal polyps of women with breast cancer.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adenomatous Polyposis Coli / metabolism*
  • Breast Neoplasms / metabolism*
  • Breast Neoplasms / pathology
  • Case-Control Studies
  • Colon / metabolism*
  • Colonoscopy
  • Cross-Sectional Studies
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Ki-67 Antigen / metabolism*
  • Middle Aged
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Rectum / metabolism*
  • Survival Rate
  • Treatment Outcome

Substances

  • Ki-67 Antigen
  • Proto-Oncogene Proteins c-bcl-2